Speaker illustration

Doctor Tilmann Kramer

Cologne University Hospital - Heart Center, Cologne (Germany)

Member of:

European Society of Cardiology

Effects of targeted therapy on blood gas analysis in pulmonary arterial hypertension - a retrospective analysis

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension - Epidemiology, prognosis, outcome 1

Thumbnail

Therapeutic effects of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH).

Event: ESC CONGRESS 2017

Topic: Chronic pulmonary hypertension

Session: Pulmonary hypertension: pathophysiology

Thumbnail

Therapeutic potential of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH).

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Pulmonary hypertension

Session: Moderated Poster session 6 - Therapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk